TEK and congenital glaucoma: One of two receptor tyrosine kinases in the angiopoietin/TEK signaling pathway, autosomal dominant mutations in TEK have been identified in patients with primary congenital glaucoma [16] and congenital glaucoma associated with sclerocornea (specific variant not reported) [36].